Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports the formation of hydrogen bonds and dipole interactions, enhancing binding affinity to target proteins. Also employed in agrochemicals for designing bioactive molecules with improved metabolic stability due to the trifluoromethyl group. Serves as a building block in medicinal chemistry for optimizing drug candidates with better pharmacokinetic profiles.